home
docs

Access to anti-retroviral drugs, female (%): Compare by Country

Browse Access to anti-retroviral drugs, female (%) across 160 countries. Select a country to view an interactive chart with historical data, cross-country comparison, and trend analysis. All data sourced from World Bank.

160 countriesSource: World Bank

Countries with Access to anti-retroviral drugs, female (%) Data— select a country to view interactive chart

Click any country to open an interactive chart with historical Access to anti-retroviral drugs, female (%) trends. You can compare multiple countries, switch time ranges, and download chart images for reports and presentations.

AfghanistanAccess to anti-retroviral drugs, female (%)Africa Eastern and SouthernAccess to anti-retroviral drugs, female (%)Africa Western and CentralAccess to anti-retroviral drugs, female (%)AlbaniaAccess to anti-retroviral drugs, female (%)AlgeriaAccess to anti-retroviral drugs, female (%)AngolaAccess to anti-retroviral drugs, female (%)Arab WorldAccess to anti-retroviral drugs, female (%)ArgentinaAccess to anti-retroviral drugs, female (%)ArmeniaAccess to anti-retroviral drugs, female (%)AustraliaAccess to anti-retroviral drugs, female (%)AzerbaijanAccess to anti-retroviral drugs, female (%)Bahamas, TheAccess to anti-retroviral drugs, female (%)BahrainAccess to anti-retroviral drugs, female (%)BangladeshAccess to anti-retroviral drugs, female (%)BarbadosAccess to anti-retroviral drugs, female (%)BelgiumAccess to anti-retroviral drugs, female (%)BelizeAccess to anti-retroviral drugs, female (%)BeninAccess to anti-retroviral drugs, female (%)BhutanAccess to anti-retroviral drugs, female (%)BoliviaAccess to anti-retroviral drugs, female (%)BotswanaAccess to anti-retroviral drugs, female (%)BulgariaAccess to anti-retroviral drugs, female (%)Burkina FasoAccess to anti-retroviral drugs, female (%)BurundiAccess to anti-retroviral drugs, female (%)Cabo VerdeAccess to anti-retroviral drugs, female (%)CambodiaAccess to anti-retroviral drugs, female (%)CameroonAccess to anti-retroviral drugs, female (%)CanadaAccess to anti-retroviral drugs, female (%)Central African RepublicAccess to anti-retroviral drugs, female (%)ChadAccess to anti-retroviral drugs, female (%)ChileAccess to anti-retroviral drugs, female (%)ColombiaAccess to anti-retroviral drugs, female (%)ComorosAccess to anti-retroviral drugs, female (%)Congo, Dem. Rep.Access to anti-retroviral drugs, female (%)Congo, Rep.Access to anti-retroviral drugs, female (%)Costa RicaAccess to anti-retroviral drugs, female (%)Cote d'IvoireAccess to anti-retroviral drugs, female (%)CroatiaAccess to anti-retroviral drugs, female (%)CubaAccess to anti-retroviral drugs, female (%)DenmarkAccess to anti-retroviral drugs, female (%)DjiboutiAccess to anti-retroviral drugs, female (%)Dominican RepublicAccess to anti-retroviral drugs, female (%)EcuadorAccess to anti-retroviral drugs, female (%)EgyptAccess to anti-retroviral drugs, female (%)El SalvadorAccess to anti-retroviral drugs, female (%)EritreaAccess to anti-retroviral drugs, female (%)EstoniaAccess to anti-retroviral drugs, female (%)EswatiniAccess to anti-retroviral drugs, female (%)EthiopiaAccess to anti-retroviral drugs, female (%)Euro areaAccess to anti-retroviral drugs, female (%)FijiAccess to anti-retroviral drugs, female (%)Fragile and conflict affected situationsAccess to anti-retroviral drugs, female (%)FranceAccess to anti-retroviral drugs, female (%)GabonAccess to anti-retroviral drugs, female (%)Gambia, TheAccess to anti-retroviral drugs, female (%)GeorgiaAccess to anti-retroviral drugs, female (%)GhanaAccess to anti-retroviral drugs, female (%)GreeceAccess to anti-retroviral drugs, female (%)GuatemalaAccess to anti-retroviral drugs, female (%)GuineaAccess to anti-retroviral drugs, female (%)Guinea-BissauAccess to anti-retroviral drugs, female (%)GuyanaAccess to anti-retroviral drugs, female (%)HaitiAccess to anti-retroviral drugs, female (%)Heavily indebted poor countries (HIPC)Access to anti-retroviral drugs, female (%)HondurasAccess to anti-retroviral drugs, female (%)IcelandAccess to anti-retroviral drugs, female (%)IDA blendAccess to anti-retroviral drugs, female (%)IDA onlyAccess to anti-retroviral drugs, female (%)IDA totalAccess to anti-retroviral drugs, female (%)IndonesiaAccess to anti-retroviral drugs, female (%)IraqAccess to anti-retroviral drugs, female (%)IrelandAccess to anti-retroviral drugs, female (%)ItalyAccess to anti-retroviral drugs, female (%)JamaicaAccess to anti-retroviral drugs, female (%)JordanAccess to anti-retroviral drugs, female (%)KazakhstanAccess to anti-retroviral drugs, female (%)KenyaAccess to anti-retroviral drugs, female (%)KuwaitAccess to anti-retroviral drugs, female (%)Kyrgyz RepublicAccess to anti-retroviral drugs, female (%)Lao PDRAccess to anti-retroviral drugs, female (%)LatviaAccess to anti-retroviral drugs, female (%)Least developed countries: UN classificationAccess to anti-retroviral drugs, female (%)LebanonAccess to anti-retroviral drugs, female (%)LesothoAccess to anti-retroviral drugs, female (%)LiberiaAccess to anti-retroviral drugs, female (%)LibyaAccess to anti-retroviral drugs, female (%)LithuaniaAccess to anti-retroviral drugs, female (%)LuxembourgAccess to anti-retroviral drugs, female (%)MadagascarAccess to anti-retroviral drugs, female (%)MalawiAccess to anti-retroviral drugs, female (%)MalaysiaAccess to anti-retroviral drugs, female (%)MaldivesAccess to anti-retroviral drugs, female (%)MaliAccess to anti-retroviral drugs, female (%)MaltaAccess to anti-retroviral drugs, female (%)MauritaniaAccess to anti-retroviral drugs, female (%)MexicoAccess to anti-retroviral drugs, female (%)Middle East, North Africa, Afghanistan & PakistanAccess to anti-retroviral drugs, female (%)Middle East, North Africa, Afghanistan & Pakistan (excluding high income)Access to anti-retroviral drugs, female (%)Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)Access to anti-retroviral drugs, female (%)MoldovaAccess to anti-retroviral drugs, female (%)MongoliaAccess to anti-retroviral drugs, female (%)MontenegroAccess to anti-retroviral drugs, female (%)MoroccoAccess to anti-retroviral drugs, female (%)MozambiqueAccess to anti-retroviral drugs, female (%)MyanmarAccess to anti-retroviral drugs, female (%)NamibiaAccess to anti-retroviral drugs, female (%)NepalAccess to anti-retroviral drugs, female (%)NetherlandsAccess to anti-retroviral drugs, female (%)New ZealandAccess to anti-retroviral drugs, female (%)NigerAccess to anti-retroviral drugs, female (%)NigeriaAccess to anti-retroviral drugs, female (%)North MacedoniaAccess to anti-retroviral drugs, female (%)OmanAccess to anti-retroviral drugs, female (%)Other small statesAccess to anti-retroviral drugs, female (%)PakistanAccess to anti-retroviral drugs, female (%)PanamaAccess to anti-retroviral drugs, female (%)Papua New GuineaAccess to anti-retroviral drugs, female (%)ParaguayAccess to anti-retroviral drugs, female (%)PeruAccess to anti-retroviral drugs, female (%)PhilippinesAccess to anti-retroviral drugs, female (%)PortugalAccess to anti-retroviral drugs, female (%)Pre-demographic dividendAccess to anti-retroviral drugs, female (%)QatarAccess to anti-retroviral drugs, female (%)RomaniaAccess to anti-retroviral drugs, female (%)RwandaAccess to anti-retroviral drugs, female (%)Saudi ArabiaAccess to anti-retroviral drugs, female (%)SenegalAccess to anti-retroviral drugs, female (%)SerbiaAccess to anti-retroviral drugs, female (%)Sierra LeoneAccess to anti-retroviral drugs, female (%)SingaporeAccess to anti-retroviral drugs, female (%)SlovakiaAccess to anti-retroviral drugs, female (%)SloveniaAccess to anti-retroviral drugs, female (%)Somalia, Fed. Rep.Access to anti-retroviral drugs, female (%)South AfricaAccess to anti-retroviral drugs, female (%)South SudanAccess to anti-retroviral drugs, female (%)SpainAccess to anti-retroviral drugs, female (%)Sri LankaAccess to anti-retroviral drugs, female (%)Sub-Saharan Africa Access to anti-retroviral drugs, female (%)Sub-Saharan Africa (excluding high income)Access to anti-retroviral drugs, female (%)Sub-Saharan Africa (IDA & IBRD countries)Access to anti-retroviral drugs, female (%)SudanAccess to anti-retroviral drugs, female (%)SurinameAccess to anti-retroviral drugs, female (%)SwedenAccess to anti-retroviral drugs, female (%)SwitzerlandAccess to anti-retroviral drugs, female (%)Syrian Arab RepublicAccess to anti-retroviral drugs, female (%)TajikistanAccess to anti-retroviral drugs, female (%)TanzaniaAccess to anti-retroviral drugs, female (%)ThailandAccess to anti-retroviral drugs, female (%)Timor-LesteAccess to anti-retroviral drugs, female (%)TogoAccess to anti-retroviral drugs, female (%)TunisiaAccess to anti-retroviral drugs, female (%)UgandaAccess to anti-retroviral drugs, female (%)United Arab EmiratesAccess to anti-retroviral drugs, female (%)United KingdomAccess to anti-retroviral drugs, female (%)Venezuela, RBAccess to anti-retroviral drugs, female (%)VietnamAccess to anti-retroviral drugs, female (%)WorldAccess to anti-retroviral drugs, female (%)Yemen, Rep.Access to anti-retroviral drugs, female (%)ZambiaAccess to anti-retroviral drugs, female (%)ZimbabweAccess to anti-retroviral drugs, female (%)

Access to anti-retroviral drugs, female (%) Data Coverage

This page lists 160 countries with available Access to anti-retroviral drugs, female (%) data. Data sourced from World Bank. Visit each country's page for interactive charts.